Burden of Chronic Kidney Disease by KDIGO Categories of Glomerular Filtration Rate and Albuminuria: A Systematic Review

Abstract

Introduction: The Kidney Disease: Improving Global Outcomes (KDIGO) 2012 guidelines recommend classifying patients by glomerular filtration rate (GFR) and albuminuria to predict chronic kidney disease (CKD) prognosis. The aim of this systematic review was to explore the epidemiological burden of CKD stratified by the KDIGO 2012 categories. Methods: MEDLINEÒ and Embase were searched for observational studies of patients with CKD with results stratified according to the KDIGO 2012 classification. Investigated outcomes were prevalence, incidence, and risk factors and complications of CKD, including mortality. Results: The review included ten observational studies with 3033 to 46,949 participants, conducted in the USA, China, France, Italy and Spain. The most frequently reported outcome was the prevalence of CKD (GFR categories G3-5), ranging from 2% to 17%. Most participants were normoalbuminuric, with 0.4-3.2% macroalbuminuric, and most fell within the KDIGO 2012 low-risk or moderate-risk groups, with 0.9-5.6% in the high-risk and 0.3-4.8% in the very high-risk groups. Although scarce, data on the prevalence of comorbidities in CKD according to the KDIGO classification suggest that they increase with albuminuria severity. Conclusions: Patients with CKD frequently have complications, but only a small proportion have severely increased albuminuria or fall within the KDIGO high-risk or very high-risk groups. These groups, however, are associated with the highest burden of disease, as comorbidities are more prevalent with increasing Electronic supplementary material The online version of this article (

Chronic Kidney Disease: Strategies to Retard Progression

“…CKD has long been a worldwide public health concern and constitutes a heavy healthcare and economic burden, as a reduced GFR is widely known to increase the risk of cardiovascular events, hospitalization, cognitive dysfunction, and overall mortality [ 2 ]. The prevalence of CKD varies according to geographic areas, mostly ranging from 10 to 20%, but rises gradually, particularly in developed countries [ 3 , 4 , 5 ]. This trend can be partially attributed to the expanding aging population globally [ 6 ].…”

Effects of Environmental Exposure to Cadmium and Lead on the Risks of Diabetes and Kidney Dysfunction

“…Low environmental exposure to Cd has been identified as a risk factor for chronic kidney disease (CKD) in cross-sectional studies in Spain [ 9 ], Korea [ 10 ], and the U.S. [ 11 , 12 , 13 , 14 , 15 ]. The diagnosis of CKD is based on albumin-to-creatinine ratio (ACR) above 30 mg/g creatinine (albuminuria) and/or a decrease in the glomerular filtration rate (GFR) to 60 mL/min/1.73 m 2 (low eGFR) that persists for at least three months [ 16 , 17 , 18 , 19 ]. In the Dallas lead project, an elevation of blood Pb ([Pb] b ) was associated with a marked reduction in eGFR among residents of a lead smelter community [ 20 ].…”

Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials

“…As CKD progresses, healthcare costs increase and health-related quality of life (HRQoL) diminishes, with the greatest costs and HRQoL burden associated with kidney failure (eGFR \ 15 mL/min/1.73 m 2 ) [5,6]. Adverse clinical outcomes, healthcare utilization and costs, and disease burden also increase as albuminuria worsens [7][8][9], and UACR 30-300 mg/g (moderately increased) and even [ 300 mg/g (severely increased) are now considered important predictors of risk for CKD progression, cardiovascular events, and mortality [4]. Early identification and pharmacologic intervention could therefore delay or prevent CKD progression.…”